BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19015853)

  • 1. Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapy.
    Dai CW; Zhang GS; Pei MF; Shen JK
    Ann Hematol; 2009 Jul; 88(7):701-2. PubMed ID: 19015853
    [No Abstract]   [Full Text] [Related]  

  • 2. Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population.
    Yang S; Yu Y; Jun-Min L; Jian-Qing M; Qiu-Sheng C; Yu C; Wei-Li Z; Jian-Hua Y; Hui-Jin Z; Yan W; Li W; Shu C; Zhi-Xiang S
    Ann Hematol; 2009 Sep; 88(9):863-9. PubMed ID: 19205655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP.
    Lin PC; Hsiao LT; Poh SB; Wang WS; Yen CC; Chao TC; Liu JH; Chiou TJ; Chen PM
    Ann Hematol; 2007 Feb; 86(2):95-100. PubMed ID: 17031689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term remission following relapsed CNS lymphoma].
    Kura Y; Sawada U; Tsuboi I; Suzuki K; Yamazaki T; Satou Y; Horie T
    Rinsho Ketsueki; 1995 Mar; 36(3):227-9. PubMed ID: 7540223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of diffuse large B-cell lymphosarcoma with involvement of bone marrow in an old female patient].
    Zamiatina VI; Kravchenko SK; Giliazitdinova EA; Magomedova AU; Vorob'ev IA; Gotman LN; Kaplanskaia IB; Kesel'man SA; Obukhova TN; Sakhibov IaD; Shevelev AA; Kremenetskaia AM
    Ter Arkh; 2008; 80(7):54-7. PubMed ID: 18763597
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
    Hosoi M; Yamamoto G; Imai Y; Kurokawa M
    Ann Hematol; 2010 Feb; 89(2):207-8. PubMed ID: 19582454
    [No Abstract]   [Full Text] [Related]  

  • 7. [A CHOP-21 course efficacy in therapy of diffuse large B-cell lymphosarcoma].
    Magomedova AU; Kravchenko SK; Kremenetskaia AM; Zvonkov EE; Moiseeva TN; Zybunova EE; Kaplanskaia IB; Samoĭlova RS; Vorob'ev IA; Lorie IuIu; Margolin OV; Giliazitdinova EA; Gubkin AV; Chernova NG; Ryzhko VV; Gemdzhian EG
    Ter Arkh; 2005; 77(7):58-61. PubMed ID: 16116911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large B-cell lymphoma of thyroid. Two cases with a marginal zone distribution of the neoplastic cells.
    Higgins JP; Warnke RA
    Am J Clin Pathol; 2000 Aug; 114(2):264-70. PubMed ID: 10941342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary large B-cell lymphoma of the bone marrow.
    Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M
    Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary malignant lymphoma arising from the nipple and areolar area of the breast].
    Nakane T; Yamane T; Shibata H; Aoyama Y; Hasegawa T; Sakamoto C; Nakamae H; Terada Y; Ohta K; Hino M
    Rinsho Ketsueki; 2003 Nov; 44(11):1107-9. PubMed ID: 14689876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challenges.
    Wobser M; Kneitz H; Bröcker EB; Becker JC
    J Dtsch Dermatol Ges; 2011 Mar; 9(3):204-11. PubMed ID: 21122066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHOP plus rituximab--balancing facts and opinion.
    Cheson BD
    N Engl J Med; 2002 Jan; 346(4):280-2. PubMed ID: 11807154
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary mediastinal large B-cell lymphoma.
    Ergul SM; Lal A; Afri L; Frei-Lahr D
    South Med J; 2002 Sep; 95(9):1005-7. PubMed ID: 12356098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epstein-Barr virus-positive diffuse large B-cell lymphoma following peripheral T-cell lymphoma, not otherwise specified: report of a case].
    Zhang F; Liu YH; Zhuang HG; Li L; Luo XL; Xu J
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):414-5. PubMed ID: 21055162
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients.
    Sar A; Perizzolo M; Stewart D; Mansoor A; Difrancesco LM; Demetrick DJ
    Leuk Res; 2009 Jun; 33(6):792-7. PubMed ID: 19054557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility, efficacy and safety of CHOP-14 in elderly patients with very high-risk diffuse large B-cell lymphoma.
    Tholstrup D; de Nully Brown P; Jurlander J; Hansen M
    Eur J Haematol; 2007 Aug; 79(2):100-6. PubMed ID: 17608712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
    Copson E
    Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case report of composite lymphoma].
    Wu J; Wang ZC; Chen XD
    Ai Zheng; 2007 Apr; 26(4):447. PubMed ID: 17430672
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial remission of a newly diagnosed diffuse large B-cell Non-Hodgkin's lymphoma in a hemodialysis patient after administration of immuno-chemotherapy with rituximab-CHOP.
    Feldmann G; Nattermann J; Gerhardt T; Nähle CP; Spengler U; Woitas R
    Int J Lab Hematol; 2007 Dec; 29(6):469-73. PubMed ID: 17988304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.